Dr. Ivor Elrifi is the chair of Cooley's global patent counseling and prosecution practice group. He advises pharmaceutical, biotechnology, life sciences and medical device companies, research institutions, universities, hospitals and governments throughout the world, particularly in the US and Europe. His practice includes patent prosecution, litigation, arbitration, licensing and transactional work with a focus on novel therapeutic treatments, biotechnology, genetics, diagnostics, biomarkers, drug formulations and medical devices.

Download full bio 


  • Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche 

  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

  • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 

  • Exscientia – $510.4 Million IPO 

  • Ovid - $75 Million IPO 

  • View all

Patent Strategy & Management Attorney of the Year – LMG Life Sciences, 2019

  • Osgoode Hall Law School, York University
    JD, 1989

  • Queen's University at Kingston
    PhD, Biology, 1986

  • Queen's University at Kingston
    BS, Biology

Admissions & Credentials



New York

Ontario, Canada

U.S. Patent and Trademark Office

Rankings & Accolades

    Chambers: Leading Patent and Life Sciences Lawyer

    Euromoney: Global Leader in Patent Law

    Fellows of the American Bar Foundation: Elected Member

    IAM Patent 1000: Leading Patent Lawyer

    Legal 500: Leading Lawyer for Patent Prosecution and Healthcare

    LMG Life Sciences: Life Sciences Star, "Patent Strategy Attorney of the Year" (Winner, 2019; Finalist, 2020 - 2022)

    Managing Intellectual Property: IP Star

    Super Lawyers: Top IP Lawyer